04 June 2022>: Clinical Research
Screening for SARS-CoV-2 Infection in Students at the Medical University of Warsaw, Poland Between November 15 and December 10, 2021 Using a Single Lateral Flow Test, the Panbio™ COVID-19 Ag Rapid Test
Mariusz Gujski 1ABCDEG , Paulina Mularczyk-Tomczewska 1BCDEF* , Filip Raciborski 2ABCDE , Piotr Samel-Kowalik 2ABCDE , Łukasz Samoliński 3ADE , Dorota Olczak-Kowalczyk 4ABDE , Mateusz Jankowski 5ABCDEFDOI: 10.12659/MSM.936962
Med Sci Monit 2022; 28:e936962
Table 4 Detailed characteristics of the participants with the positive Panbio™ COVID-19 Ag Rapid Test.
Field of the study | Group ID code | Age (years) | Gender | Vaccinated | COVID-19 vaccine (first dose) | Number of vaccine doses | Date of last vaccine dose | COVID-19 in the past |
---|---|---|---|---|---|---|---|---|
Medicine | L5-20- | 23 | Male | Yes | Pfizer | 3 | Oct 2021 | No |
Medicine | L5-12- | 23 | Female | Yes | Pfizer | 3 | Oct 2021 | No |
Medicine | L5-19- | 23 | Female | Yes | Pfizer | 2 | Feb 2021 | No |
Dentistry | D3-01- | 20 | Female | Yes | AstraZeneca | 2 | May 2021 | No |
Dentistry | D3-N1- | 21 | Female | Yes | AstraZeneca | 2 | May 2021 | Yes |
Dentistry | D3-N1- | 22 | Male | Yes | Pfizer | 2 | Feb 2021 | No |
Dentistry | D3-N1- | 21 | Female | Yes | Pfizer | 2 | Feb 2021 | No |
Dentistry | D3-N1- | 22 | Female | Yes | AstraZeneca | 2 | Jun 2021 | No |
Nursing | I3-08A- | 22 | Female | No | – | – | – | No |
Nursing | I3-08A- | 21 | Female | Yes | Pfizer | 2 | Feb 2021 | No |
Nursing | I3-03B- | 22 | Female | Yes | Pfizer | 2 | Feb 2021 | No |
Nursing | I3-03B- | 20 | Female | Yes | Pfizer | 2 | Feb 2021 | No |
Nursing | I3-03B- | 21 | Female | Yes | AstraZeneca | 2 | Jun 2021 | No |
Nursing | I3-03A- | 21 | Female | Yes | AstraZeneca | 2 | Jun 2021 | No |
Dietetics | B5-P1- | 23 | Female | Yes | AstraZeneca | 2 | Jun 2021 | No |